Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DILV59
|
|||
| Drug Name |
HB-101
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Cytomegalovirus Disease [ICD-11: 1D82] | Phase 2 | [1] | |
| Company |
Hookipa Pharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03629080) A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.